| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |